冠狀動脈支架市場規模、佔有率和成長分析（按類型、輸送方式、材料、最終用戶和地區分類）—產業預測（2026-2033 年）

預計到 2024 年，冠狀動脈支架市場規模將達到 4,484.7 億美元，到 2025 年將達到 4,726.8 億美元，到 2033 年將達到 7,199.4 億美元，預測期（2026-2033 年）的複合年成長率為 5.4%。

由於心血管疾病發生率不斷上升和人口老化，冠狀動脈支架市場正經歷強勁成長。生活方式的改變導致冠狀動脈疾病等疾病的盛行率不斷上升，進而推動了對冠狀動脈支架的需求成長。微創手術的普及也進一步促進了支架的採用。支架技術的創新，特別是藥物釋放型和生物可吸收支架的出現，改善了患者的治療效果，降低了血管再阻塞的風險，從而促進了支架從傳統裸金屬支架向更高級支架的轉變。儘管存在這些積極趨勢，但仍存在一些挑戰，例如高昂的手術費用可能會限制低收入地區的患者獲得治療，以及嚴格的監管要求會使新產品的核准流程複雜化。此外，支架血栓症和血管再阻塞等併發症仍然是患者和醫療服務提供者關注的問題，影響整體市場趨勢。

冠狀動脈支架市場促進因素

心血管疾病，尤其是冠狀動脈疾病的日益流行，是全球冠狀動脈支架市場的主要驅動力。生活方式的改變、不合理的飲食以及缺乏運動等因素加劇了這一日益嚴重的健康問題。隨著越來越多的人受到這些生活方式相關問題的影響，對冠狀動脈支架等有效醫療干預措施的需求也隨之成長。因此，醫療服務提供者和製造商不得不滿足這一迫切需求，從而進一步推動了市場成長。對改善心血管健康和控制相關風險的普遍關注，凸顯了冠狀動脈支架在現代醫療解決方案中的重要作用。

冠狀動脈支架市場的限制因素

由於衛生監管機構嚴格的核准流程，冠狀動脈支架市場面臨許多挑戰。這些嚴格的要求促使製造商進行全面的安全性和有效性評估，而這往往耗費大量時間和資源。由此產生的漫長而複雜的核准流程可能會延緩創新產品的上市。這項挑戰限制了市場成長機會，並可能降低患者獲得先進支架技術的機會，最終影響整個冠狀動脈支架市場的發展。因此，克服這些監管障礙對於促進該領域的創新和改善患者照護至關重要。

冠狀動脈支架市場趨勢

冠狀動脈支架市場正呈現向微創手術顯著發展的趨勢，這主要得益於經經皮冠狀動脈介入治療（PCI）的日益普及。這一轉變反映了醫療保健領域整體以改善患者預後為導向的趨勢，因為與傳統開胸手術相比，微創手術能夠縮短住院時間、加快康復速度並降低併發症風險。隨著醫療機構將患者的舒適度和效率放在首位，對先進冠狀動脈支架的需求預計將大幅成長，從而推動支架設計和輸送系統的創新，以滿足心血管護理領域不斷變化的需求。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球冠狀動脈支架市場規模（按類型及複合年成長率分類）（2026-2033 年）

• 裸金屬支架
• 藥物釋放型支架
• 生物可吸收支架

全球冠狀動脈支架市場規模（按交付量和複合年成長率分類）（2026-2033 年）

• 球囊擴張型支架
• 自動擴張型支架

全球冠狀動脈支架市場規模（按材料和複合年成長率分類）（2026-2033 年）

• 金屬支架
• 鈷鉻
• 鉑金鉻
• 鎳鈦
• 不銹鋼
• 其他支架

全球冠狀動脈支架市場規模（依最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 心臟中心
• 門診手術中心

全球冠狀動脈支架市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Abbott Laboratories（USA）
• Medtronic plc（Ireland）
• Boston Scientific Corporation（USA）
• Biosensors International Group, Ltd.（Singapore）
• Biotronik SE & Co. KG（Germany）
• B. Braun Melsungen AG（Germany）
• Terumo Corporation（Japan）
• MicroPort Scientific Corporation（China）
• Lepu Medical Technology（Beijing）Co., Ltd.（China）
• Sahajanand Medical Technologies Pvt. Ltd.（India）
• Meril Life Sciences Pvt. Ltd.（India）
• Vascular Concepts（India）
• Translumina GmbH（Germany）
• Cordis Corporation（USA）
• Reva Medical, Inc.（USA）
• Elixir Medical Corporation（USA）
• Stentys SA（France）
• Alvimedica（Turkey）
• Balton Medical（Sweden）
• Cardionovum（USA）

結論與建議

Coronary Stent Market size was valued at USD 448.47 Billion in 2024 and is poised to grow from USD 472.68 Billion in 2025 to USD 719.94 Billion by 2033, growing at a CAGR of 5.4% during the forecast period (2026-2033).

The coronary stent market is experiencing robust growth influenced by an increasing incidence of cardiovascular diseases and an aging population. As lifestyle changes contribute to higher rates of conditions like coronary artery disease, the demand for coronary stents is escalating. The shift towards minimally invasive procedures further drives adoption. Innovations in stent technology, particularly drug-eluting and bioresorbable designs, have enhanced patient outcomes and reduced restenosis risks, prompting a transition from traditional bare-metal options. Despite this positive trend, challenges persist, including high procedural costs that may restrict access in lower-income regions and stringent regulatory requirements that complicate approval processes for new products. Additionally, complications like stent thrombosis and restenosis remain concerns for patients and healthcare providers, impacting overall market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Coronary Stent market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Coronary Stent Market Segments Analysis

Global Coronary Stent Market is segmented by type, delivery, material, end user and region. Based on type, the market is segmented into bare-metal stents, drug-eluting stents and bioabsorbable stents. Based on delivery, the market is segmented into balloon-expandable stents and self-expanding stents. Based on material, the market is segmented into metallic stents, cobalt chromium, platinum chromium, nickel titanium, stainless steel and other stents. Based on end user, the market is segmented into hospitals, cardiac centers and ambulatory surgical centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Coronary Stent Market

The increasing prevalence of cardiovascular diseases, particularly coronary artery disease, significantly propels the global coronary stent market. Factors such as shifts in lifestyle, poor dietary habits, and a lack of physical activity have all contributed to this escalating health concern. As more individuals face the consequences of these lifestyle-related issues, the demand for effective medical interventions, such as coronary stents, rises. Consequently, healthcare providers and manufacturers are compelled to respond to this urgent need, further driving market growth. The overall focus on improving cardiovascular health and managing associated risks emphasizes the crucial role of coronary stents in contemporary healthcare solutions.

Restraints in the Coronary Stent Market

The coronary stent market faces significant obstacles due to the rigorous regulatory approval processes enforced by health authorities. These stringent requirements necessitate that manufacturers undergo thorough safety and efficacy evaluations, which often consume considerable time and resources. As a result, the lengthy and complex approval procedures can hinder the timely introduction of innovative products into the market. This challenge can restrict growth opportunities and limit the availability of advanced stent technologies for patients, ultimately affecting the overall development of the coronary stent market. Addressing these regulatory hurdles is essential for fostering innovation and enhancing patient care in this field.

Market Trends of the Coronary Stent Market

The coronary stent market is witnessing a notable trend favoring minimally invasive procedures, primarily driven by the increasing adoption of percutaneous coronary intervention (PCI). This shift reflects a broader healthcare emphasis on enhancing patient outcomes, as minimally invasive approaches facilitate shorter hospital stays, quicker recovery times, and a decreased risk of complications when compared to traditional open-heart surgeries. As healthcare providers prioritize patient comfort and efficiency, the demand for advanced coronary stents is expected to surge, fostering innovations in stent design and delivery systems that align with these evolving preferences in cardiovascular care.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Coronary Stent Market Size by Type & CAGR (2026-2033)

• Market Overview
• Bare-Metal Stents
• Drug-Eluting Stents
• Bioabsorbable Stents

Global Coronary Stent Market Size by Delivery & CAGR (2026-2033)

• Market Overview
• Balloon-Expandable Stents
• Self-Expanding Stents

Global Coronary Stent Market Size by Material & CAGR (2026-2033)

• Market Overview
• Metallic Stents
• Cobalt Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Other Stents

Global Coronary Stent Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Centers
• Ambulatory Surgical Centers

Global Coronary Stent Market Size & CAGR (2026-2033)

• North America (Type, Delivery, Material, End User)
  • US
  • Canada
• Europe (Type, Delivery, Material, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Delivery, Material, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Delivery, Material, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Delivery, Material, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biosensors International Group, Ltd. (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lepu Medical Technology (Beijing) Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sahajanand Medical Technologies Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Concepts (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Translumina GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cordis Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reva Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elixir Medical Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stentys SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alvimedica (Turkey)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Balton Medical (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardionovum (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations